期刊
HUMAN VACCINES & IMMUNOTHERAPEUTICS
卷 13, 期 4, 页码 836-842出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/21645515.2016.1251536
关键词
antibody engineering; antibody therapeutics; antiviral; bifunctional antibodies; bispecific antibodies; immunotherapy; passive immunization; virology
资金
- NIH [U19-AI109762]
- DAAD (Deutscher Akademischer Austausch Dienst, German Academic Exchange Service)
Bispecific antibody engineering, in which binding specificities toward 2 distinct epitopes are combined into a single molecule, can greatly enhance immunotherapeutic properties of monoclonal antibodies. While the bispecific antibody approach has been applied widely to targets for indications such as cancer and inflammation, the development of such agents for viral immunotherapy is only now emerging. Here, we review recent advances in the development of bispecific antibodies for viral immunotherapy, highlighting promising in vitro and in vivo results.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据